A combination therapy improved progression-free survival in patients with metastatic castration-resistant prostate cancer with distinct genetic mutations compared to either therapy alone or sequentially, according to results from a Northwestern Medicine-led multi-center clinical trial published in the journal Clinical Cancer Research.
Combination treatment improves survival in advanced prostate cancer with genetic mutations retrieved 9 September 2024 from https://medicalxpress.com/news/2024-09-combination-treatment-survival-advanced-prostate.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.
Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.
Medicine Research Health Research News Health Research Health Science Medicine Science
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Low-dose triple-pill combination outperforms standard care for blood pressure control in Nigerian adultsA low-dose triple single-pill combination-based protocol achieved better blood pressure (BP) control than a standard-care protocol in Black African Nigerian adults with uncontrolled hypertension, according to late-breaking research presented in a Hot Line session today at ESC Congress 2024.
Read more »
Triple-pill combination GMRx2 outperforms standard care in lowering blood pressureNew research shows that a treatment plan based on novel combination of low doses of three anti-hypertensive drugs in a single pill - known as GMRx2 - was superior to a high-quality standard care treatment plan at lowering blood pressure in patients with uncontrolled hypertension.
Read more »
Novel low-dose triple single-pill combination shows efficacy and tolerability in two international trialsA low-dose triple single-pill combination was effective at lowering blood pressure (BP) in two trials presented in a Hot Line session today at ESC Congress 2024.
Read more »
New protocol explores the combination of aerobic exercise and cognitive rehabilitation for MS patientsResearchers at Kessler Foundation have published a new clinical protocol examining the combination of aerobic exercise and cognitive rehabilitation to improve learning and memory in individuals with multiple sclerosis (MS) who have mobility disability.
Read more »
New combination therapy may offer a safer, more effective treatment for colorectal cancerResearchers from the University of Alabama at Birmingham have identified a promising new combination therapy for metastatic colorectal cancer that enhances the effectiveness of existing treatment while reducing harmful side effects.
Read more »
UC's Eric Vick receives major grants to advance research into combination therapy for leukemiaThe University of Cincinnati Cancer Center's Eric Vick, MD, PhD, has been awarded a nearly $215,000 Career Development Award from the Leukemia and Lymphoma Society (LLS) and a $50,000 American Society of Clinical Oncology (ASCO) Young Investigator Award to continue research into a combination therapy treatment for acute myeloid leukemia (AML).
Read more »